National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 02/12/2008



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Treatment Option Overview






Localized Non-Hodgkin Lymphoma in Children and Adolescents






Disseminated Childhood B-cell Non-Hodgkin Lymphoma






Disseminated Childhood Lymphoblastic Lymphoma






Disseminated Childhood Anaplastic Large Cell Lymphoma






Recurrent Childhood Non-Hodgkin Lymphoma






Lymphoproliferative Disease Associated With Immunodeficiency in Children






Get More Information From NCI







Changes to This Summary (02/19/2008)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Changes to This Summary (02/19/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Cellular Classification

Added text to state that in a retrospective subset analysis, there was evidence that submicroscopic bone marrow and peripheral blood involvement were found in approximately 50% of patients and correlated with clinical stage; marrow involvement detected by PCR was associated with a 50% cumulative incidence of relapse (cited Damm-Welk et al. as reference 23).

Added Grewal et al. as reference 25.

Added text to state that one report of children with primary CNS lymphoma showed that most patients had diffuse large B-cell lymphoma or ALCL and that therapy with high-dose intravenous methotrexate and cytosine arabinoside was most successful; intravenous chemotherapy may be needed only when malignant cells are present in the cerebral spinal fluid.

Stage Information

Added text about the prevalence, clinical pattern, and outcome of CNS involvement in NHL patients (cited Salzburg et al. as reference 2).

Disseminated Childhood Anaplastic Large Cell Lymphoma

Added Grewal et al. as reference 6.

Added text to state that one study suggested that the amount of tumor involvement as measured by PCR in the marrow is predictive for relapse (cited Damm-Welk as reference 7).

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov